The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Nanobody: The “Magic Bullet” for Molecular Imaging?
Open accessAbstract
Molecular imaging involves the non-invasive investigation of biological processes in vivo at the cellular and molecular level, which can play diverse roles in better understanding and treatment of various diseases. Recently, single domain antigen-binding fragments known as 'nanobodies' were bioengineered and tested for molecular imaging applications. Small molecular size (~15 kDa) and suitable configuration of the complementarity determining regions (CDRs) of nanobodies offer many desirable features suitable for imaging applications, such as rapid targeting and fast blood clearance, high solubility, high stability, easy cloning, modular nature, and the capability of binding to cavities and difficult-to-access antigens. Using nanobody-based probes, several imaging techniques such as radionuclide-based, optical and ultrasound have been employed for visualization of target expression in various disease models. This review summarizes the recent developments in the use of nanobody-based probes for molecular imaging applications. The preclinical data reported to date are quite promising, and it is expected that nanobody-based molecular imaging agents will play an important role in the diagnosis and management of various diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,364
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656
van Dam, G. M., Themelis, G., Crane, L. M. A., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J. G., van der Zee, A. G. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2472 · Cited by 1,545
Image-guided cancer surgery using near-infrared fluorescence
Vahrmeijer, A. L., Hutteman, M., van der Vorst, J. R., van de Velde, C. J. H., & Frangioni, J. V. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.123 · Cited by 1,466
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
Ametamey, S. M., Honer, M., & Schubiger, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0782426 · Cited by 1,271
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Arming antibodies: prospects and challenges for immunoconjugates
Wu, A. M., & Senter, P. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1141 · Cited by 1,052
Properties, production, and applications of camelid single-domain antibody fragments
Harmsen, M. M., & De Haard, H. J. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1142-2 · Cited by 809 · cited 4×
“The detailed procedures for these processes have been well-documented in the literature and will not be discussed here [34, 37, 40].”
BackgroundInfluentialLi, H., Cybulsky, M. I., Gimbrone, M. A., & Libby, P. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.197 · Cited by 689
Vincke, C., Loris, R., Saerens, D., Martinez-Rodriguez, S., Muyldermans, S., & Conrath, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806889200 · Cited by 572
NAKAMURA, T., & MIZUNO, S. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.588 · Cited by 547
Seven challenges for nanomedicine
Sanhai, W. R., Sakamoto, J. H., Canady, R., & Ferrari, M. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.114 · Cited by 538
Camelid immunoglobulins and nanobody technology
Muyldermans, S., Baral, T. N., Retamozzo, V. C., De Baetselier, P., De Genst, E., Kinne, J., Leonhardt, H., Magez, S., Nguyen, V. K., Revets, H., et al. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.10.299 · Cited by 533
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F., et al. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0116-7 · Cited by 513
Synthesis and Biomedical Applications of Copper Sulfide Nanoparticles: From Sensors to Theranostics
Goel, S., Chen, F., & Cai, W. (2014) · Small · doi:10.1002/smll.201301174 · Cited by 464
Self-citationEpidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?
Arteaga, C. L. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-31 · Cited by 455
‘Two is better than one’—probes for dual-modality molecular imaging
Jennings, L. E., & Long, N. J. (2009) · Chemical Communications · doi:10.1039/b821903f · Cited by 438
Choi, K. Y., Liu, G., Lee, S., & Chen, X. (2012) · Nanoscale · doi:10.1039/c1nr11277e · Cited by 437
FAUSTO, N. (1991) · Hepatology · doi:10.1016/0270-9139(91)90068-7 · Cited by 418
Optical Imaging: Current Applications and Future Directions
Luker, G. D., & Luker, K. E. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045799 · Cited by 404
Carbon nanotubes for biomedical imaging: The recent advances
Gong, H., Peng, R., & Liu, Z. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.002 · Cited by 389
Molecular Imaging: Looking at Problems, Seeing Solutions
Herschman, H. R. (2003) · Science · doi:10.1126/science.1090585 · Cited by 382
Chen, F., Hong, H., Zhang, Y., Valdovinos, H. F., Shi, S., Kwon, G. S., Theuer, C. P., Barnhart, T. E., & Cai, W. (2013) · ACS Nano · doi:10.1021/nn403617j · Cited by 346
Self-citationNanobodies and Their Potential Applications
Hassanzadeh-Ghassabeh, G., Devoogdt, N., De Pauw, P., Vincke, C., & Muyldermans, S. (2013) · Nanomedicine · doi:10.2217/nnm.13.86 · Cited by 328
Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer
Vaneycken, I., Devoogdt, N., Van Gassen, N., Vincke, C., Xavier, C., Wernery, U., Muyldermans, S., Lahoutte, T., & Caveliers, V. (2011) · The FASEB Journal · doi:10.1096/fj.10-180331 · Cited by 315
Tijink, B. M., Laeremans, T., Budde, M., Walsum, M. S.-V., Dreier, T., de Haard, H. J., Leemans, C. R., & van Dongen, G. A. M. S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2384 · Cited by 305
Movahedi, K., Schoonooghe, S., Laoui, D., Houbracken, I., Waelput, W., Breckpot, K., Bouwens, L., Lahoutte, T., De Baetselier, P., Raes, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2994 · Cited by 291
Peptide-Based Probes for Cancer Imaging
Reubi, J. C., & Maecke, H. R. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053041 · Cited by 286
Length distribution of CDRH3 in antibodies
Wu, T. T., Johnson, G., & Kabat, E. A. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160102 · Cited by 284
Baum, R. P., & Kulkarni, H. R. (2012) · Theranostics · doi:10.7150/thno.3645 · Cited by 283
Core–Shell Lanthanide Upconversion Nanophosphors as Four-Modal Probes for Tumor Angiogenesis Imaging
Sun, Y., Zhu, X., Peng, J., & Li, F. (2013) · ACS Nano · doi:10.1021/nn405082y · Cited by 282
Nanobodies as novel agents for cancer therapy
Revets, H., De Baetselier, P., & Muyldermans, S. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.111 · Cited by 254
Xavier, C., Vaneycken, I., D’huyvetter, M., Heemskerk, J., Keyaerts, M., Vincke, C., Devoogdt, N., Muyldermans, S., Lahoutte, T., & Caveliers, V. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111021 · Cited by 230
Olafsen, T., & Wu, A. M. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.12.005 · Cited by 223
Latest Advances in Molecular Imaging Instrumentation
Pichler, B. J., Wehrl, H. F., & Judenhofer, M. S. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.045880 · Cited by 223
Gainkam, L. O. T., Huang, L., Caveliers, V., Keyaerts, M., Hernot, S., Vaneycken, I., Vanhove, C., Revets, H., De Baetselier, P., & Lahoutte, T. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048538 · Cited by 222
Computer-aided antibody design
Kuroda, D., Shirai, H., Jacobson, M. P., & Nakamura, H. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs024 · Cited by 222
Targeting tumors with nanobodies for cancer imaging and therapy
Oliveira, S., Heukers, R., Sornkom, J., Kok, R. J., & van Bergen en Henegouwen, P. M. P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.298 · Cited by 206
Li, H., Cybulsky, M. I., Gimbrone, M. A., & Libby, P. (1993) · PubMed Central · Cited by 203
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
Broisat, A., Hernot, S., Toczek, J., De Vos, J., Riou, L. M., Martin, S., Ahmadi, M., Thielens, N., Wernery, U., Caveliers, V., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.265140 · Cited by 200
Oliveira, S., van Dongen, G. A. M. S., Walsum, M. S.-V., Roovers, R. C., Stam, J. C., Mali, W., van Diest, P. J., & van Bergen en Henegouwen, P. M. P. (2012) · Molecular Imaging · doi:10.2310/7290.2011.00025 · Cited by 194
SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression
Huang, L., Gainkam, L. O. T., Caveliers, V., Vanhove, C., Keyaerts, M., De Baetselier, P., Bossuyt, A., Revets, H., & Lahoutte, T. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0133-8 · Cited by 192
Kim, Y., Jeon, J., Hong, S. H., Rhim, W., Lee, Y., Youn, H., Chung, J., Lee, M. C., Lee, D. S., Kang, K. W., et al. (2011) · Small · doi:10.1002/smll.201100927 · Cited by 189
Cybulsky, M. I., Fries, J. W., Williams, A. J., Sultan, P., Eddy, R., Byers, M., Shows, T., Gimbrone, M. A., & Collins, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7859 · Cited by 184
Molecular imaging perspectives
Cassidy, P. J., & Radda, G. K. (2005) · Journal of The Royal Society Interface · doi:10.1098/rsif.2005.0040 · Cited by 169
Engineered antibodies for molecular imaging of cancer
Wu, A. M. (2014) · Methods · doi:10.1016/j.ymeth.2013.09.015 · Cited by 166
Positron emission tomography (PET) imaging with (18)F-based radiotracers.
Alauddin, M. M. (2012) · PubMed · Cited by 165
Molecular Imaging: The Vision and Opportunity for Radiology in the Future
Hoffman, J. M., & Gambhir, S. S. (2007) · Radiology · doi:10.1148/radiol.2441060773 · Cited by 160
Advances in Molecular Imaging: Targeted Optical Contrast Agents for Cancer Diagnostics
Hellebust, A., & Richards-Kortum, R. (2012) · Nanomedicine · doi:10.2217/nnm.12.12 · Cited by 159
Harris, N., Super, M., Rits, M., Chang, G., & Ezekowitz, R. A. B. (1992) · Blood · doi:10.1182/blood.v80.9.2363.2363 · Cited by 155
Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
Vosjan, M. J. W. D., Vercammen, J., Kolkman, J. A., van Walsum, M., Revets, H., & van Dongen, G. A. M. S. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0891 · Cited by 150
Gainkam, L. O. T., Caveliers, V., Devoogdt, N., Vanhove, C., Xavier, C., Boerman, O. C., Muyldermans, S., Bossuyt, A. M., & Lahoutte, T. (2010) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.408 · Cited by 148
Immuno-imaging using nanobodies
Vaneycken, I., D’Huyvetter, M., Hernot, S., Vos, J. D., Xavier, C., Devoogdt, N., Caveliers, V., & Lahoutte, T. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.009 · Cited by 142
Ladenson, R. C., Crimmins, D. L., Landt, Y., & Ladenson, J. H. (2006) · Analytical Chemistry · doi:10.1021/ac058044j · Cited by 142
Vos, J. D., Devoogdt, N., Lahoutte, T., & Muyldermans, S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.800478 · Cited by 138
Recent trends in antibody-based oncologic imaging
Kaur, S., Venktaraman, G., Jain, M., Senapati, S., Garg, P., & Batra, S. K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.017 · Cited by 138
Unparalleled Contribution of Technetium-99m to Medicine Over 5 Decades
Eckelman, W. C. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.12.013 · Cited by 137
Chelator‐Free Synthesis of a Dual‐Modality PET/MRI Agent
Chen, F., Ellison, P. A., Lewis, C. M., Hong, H., Zhang, Y., Shi, S., Hernandez, R. T., Meyerand, M. E., Barnhart, T. E., & Cai, W. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306306 · Cited by 133
Self-citationVosjan, M. J. W. D., Perk, L. R., Roovers, R. C., Visser, G. W. M., van Walsum, M., Henegouwen, P. M. P. V. B. E., & van Dongen, G. A. M. S. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1700-1 · Cited by 116
Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types
Groeve, K. D., Deschacht, N., Koninck, C. D., Caveliers, V., Lahoutte, T., Devoogdt, N., Muyldermans, S., BAETSELIER, P. D., & Raes, G. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.070078 · Cited by 108
Nanocarriers for Diagnosis and Targeting of Breast Cancer
Sharma, A. K., Jain, N. K., & Sareen, R. (2013) · BioMed Research International · doi:10.1155/2013/960821 · Cited by 107
Capala, J., & Bouchelouche, K. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833f8c3a · Cited by 106
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody
Pruszyński, M., Koumarianou, E., Vaidyanathan, G., Revets, H., Devoogdt, N., Lahoutte, T., & Zalutsky, M. R. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.08.008 · Cited by 105
Molecular imaging with SPECT as a tool for drug development
Gomes, C. M., Abrunhosa, A. J., Ramos, P., & Pauwels, E. K. J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.015 · Cited by 100
Multimodality imaging of the HER-kinase axis in cancer
Cai, W., Niu, G., & Chen, X. S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0560-9 · Cited by 99
Self-citationImaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies
Lemaire, M., D’Huyvetter, M., Lahoutte, T., Valckenborgh, E. V., Menu, E., Bruyne, E. D., Kronenberger, P., Wernery, U., Muyldermans, S., Devoogdt, N., et al. (2013) · Leukemia · doi:10.1038/leu.2013.292 · Cited by 98
Nanobody-coupled microbubbles as novel molecular tracer
Hernot, S., Unnikrishnan, S., Du, Z., Shevchenko, T. I., Cosyns, B., Broisat, A., Toczek, J., Caveliers, V., Muyldermans, S., Lahoutte, T., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.007 · Cited by 98
Shi, S., Chen, F., & Cai, W. (2013) · Nanomedicine · doi:10.2217/nnm.13.177 · Cited by 94
Self-citationPut, S., Schoonooghe, S., Devoogdt, N., Schurgers, E., Avau, A., Mitera, T., D’Huyvetter, M., BAETSELIER, P. D., Raes, G., Lahoutte, T., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111781 · Cited by 93
Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management
Velikyan, I. (2012) · Theranostics · doi:10.7150/thno.4428 · Cited by 73
A 3D ultrasound scanning system for image guided liver interventions
Neshat, H., Cool, D. W., Barker, K. C., Gardi, L., Kakani, N. K., & Fenster, A. (2013) · Medical Physics · doi:10.1118/1.4824326 · Cited by 71
Engineering antibodies and proteins for molecular in vivo imaging
Romer, T., Leonhardt, H., & Rothbauer, U. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.007 · Cited by 63
Osteoclastogenesis and arthritis
Maruotti, N., Grano, M., Colucci, S. C., Donofrıo, F., & Cantatore, F. P. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0117-2 · Cited by 62
PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.
Balyasnikova, S., Löfgren, J., de Nijs, R., Zamogilnaya, Y., Højgaard, L., & Fischer, B. M. (2012) · Europe PMC (PubMed Central) · Cited by 59
Schoonooghe, S., Laoui, D., Ginderachter, J. A. V., Devoogdt, N., Lahoutte, T., BAETSELIER, P. D., & Raes, G. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.009 · Cited by 54
Molecular imaging probe development: a chemistry perspective.
Nolting, D. D., Nickels, M. L., Guo, N., & Pham, W. N. (2012) · Europe PMC (PubMed Central) · Cited by 53
van der Meel, R., Gallagher, W. M., Oliveira, S., O’Connor, A. E., Schiffelers, R. M., & Byrne, A. T. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.12.003 · Cited by 52
Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature
Kim, B., Yang, J., Hwang, M., Choi, J., Kim, H., Jang, E., Lee, J. H., Ryu, S. H., Suh, J., Huh, Y., et al. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-399 · Cited by 49
An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers
Varmira, K., Hosseinimehr, S. J., Noaparast, Z., & Abedi, S. M. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.839688 · Cited by 47
Optical imaging of tumor microenvironment.
Wu, Y., Zhang, W., Li, J., & Zhang, Y. (2013) · PubMed · Cited by 45
Zabetakis, D., Anderson, G. P., Bayya, N., & Goldman, E. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077678 · Cited by 43
Altıntaş, I., Kok, R. J., & Schiffelers, R. M. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.015 · Cited by 43
Morishima, S., Morita, I., Tokushima, T., Kawashima, H., Miyasaka, M., Omura, K., & Murota, S. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760285 · Cited by 43
Lindner, J. R. (2002) · Current Problems in Cardiology · doi:10.1067/mcd.2002.129364 · Cited by 43
Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen
Hong, H., Sun, J., & Cai, W. (2008) · Biomarker Insights · doi:10.4137/bmi.s1124 · Cited by 41
Self-citationPET radiopharmaceuticals for probing enzymes in the brain.
Holland, J. P., Cumming, P. D., & Vasdev, N. (2013) · Europe PMC (PubMed Central) · Cited by 37
McAteer, M. A., & Choudhury, R. P. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.10.005 · Cited by 31
Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression
Niu, G. (2007) · Frontiers in bioscience · doi:10.2741/2720 · Cited by 30
Optical and Opto-Acoustic Imaging
Ntziachristos, V., & Razansky, D. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-10853-2_4 · Cited by 24
Molecular Imaging Using Nanobodies: A Case Study
Devoogdt, N., Xavier, C., Hernot, S., Vaneycken, I., D’Huyvetter, M., Vos, J. D., Massa, S., BAETSELIER, P. D., Caveliers, V., & Lahoutte, T. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-968-6_35 · Cited by 20
Jiang, W., Rosenberg, J. N., Wauchope, A. D., Tremblay, J. M., Shoemaker, C. B., Weeks, D. P., & Oyler, G. A. (2013) · The Plant Journal · doi:10.1111/tpj.12316 · Cited by 15
Dual-Modality, Dual-Functional Nanoprobes for Cellular and Molecular Imaging
Menon, J. U., Gulaka, P., McKay, M. A., Geethanath, S., Liu, L., & Kodibagkar, V. D. (2012) · Theranostics · doi:10.7150/thno.4812 · Cited by 14
Over a Hump for Imaging Atherosclerosis
Nahrendorf, M., McCarthy, J. R., & Libby, P. (2012) · Circulation Research · doi:10.1161/circresaha.112.267260 · Cited by 13
Chelator‐Free Synthesis of a Dual‐Modality PET/MRI Agent
Chen, F., Ellison, P. A., Lewis, C. M., Hong, H., Zhang, Y., Shi, S., Hernandez, R. T., Meyerand, M. E., Barnhart, T. E., & Cai, W. (2013) · Angewandte Chemie · doi:10.1002/ange.201306306 · Cited by 12
Self-citationEATRIS, a European initiative to boost translational biomedical research.
van Dongen, G. A. M. S., Ussi, A. E., de Man, F. H., & Migliaccio, G. (2013) · Europe PMC (PubMed Central) · Cited by 11
Cited by
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Bannas, P., Hambach, J., & Koch-Nolte, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01603 · Cited by 572
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Self-citationNanobodies as therapeutics: big opportunities for small antibodies
Steeland, S., Vandenbroucke, R. E., & Libert, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.003 · Cited by 468
Radiochemistry for positron emission tomography
Rong, J., Haider, A., Jeppesen, T. E., Josephson, L., & Liang, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-36377-4 · Cited by 294
Metadata
- Authors
- Chakravarty, R., Goel, S., & Cai, W.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2014
- Volume
- 4
- Issue
- 4
- Pages
- 386-398
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2098210920
- Cited by
- 288
- References
- 105
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.